Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases.
about
Natural killer T (NKT) cells accelerate Shiga toxin type 2 (Stx2) pathology in mice.Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: disease activity and the use of cytotoxic drugs.Thrombotic thrombocytopenic purpura (TTP): initial treatment with plasma exchange plus steroids and immunosuppressive agents for relapsing cases.Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.Thrombotic thrombocytopenic purpura in southern Turkey: a single-center experience of 29 cases.Predictors of response and relapse in a cohort of adults with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a single-institution experience.A comparison of thrombotic thrombocytopenic purpura in an inception cohort of patients with and without systemic lupus erythematosus.Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the 10-year experience of a single center.Retrospective review of 25 cases of thrombotic thrombocytopenic purpura in Pakistan.Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies.Management and outcomes for patients with TTP: analysis of 100 cases at a single institution.Postoperative thrombotic thrombocytopenic purpura.Hematopoietic stem cell transplant-associated thrombotic microangiopathy: review of pharmacologic treatment options.Hospital-acquired thrombocytopenia.A phase-II sequential case-series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab.Re-examination of 30-day survival and relapse rates in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.Long-term outcomes of thrombotic microangiopathy treated with plasma exchange: A systematic review.Thrombotic thrombocytopenic purpura - analysis of clinical features, laboratory characteristics and therapeutic outcome of 24 patients treated at a Tertiary Care Center in Saudi Arabia.Detection of Plasma Protease Activity Using Microsphere-Cytometry Assays with E. coli Derived Substrates: VWF Proteolysis by ADAMTS13A review of hereditary and acquired coagulation disorders in the aetiology of ischaemic stroke.Diagnosis and management of atypical hemolytic uremic syndrome in children: single centre experience.Thrombotic microangiopathies
P2860
Q30300135-F339D269-2881-4BF5-9836-EC53B3F76970Q33343912-7F4E9426-36E6-4372-B255-2F57BBCD9CFCQ33346797-F8A52FF1-DC83-4F47-B9EC-4AFD0B028E2EQ33361758-441C7E16-0C8A-4D6A-BEE6-3BD80F73C9C8Q33365524-93D88775-9FC7-49BF-ABB0-307ED03EB21CQ33373783-5EFB6C5B-B92F-45A3-9B29-95347C255DAEQ33383190-3D855BDD-865E-4D81-860B-7CDE7DFE9BB8Q33394558-31F3F92A-BE73-4880-A7DB-33158D343E15Q33399210-66BC5364-287A-4DD2-9C3A-88C70EFFBCDAQ33401197-92119E0E-8019-4E4A-91BC-54AA83459541Q33401403-D96F2EE6-70D7-4526-B648-1ED6F87B9AE3Q33407187-BC658594-E025-4F65-9214-CE602AD3F46CQ33412350-2AE28962-6DA4-43DB-80B1-1B9A046EA19DQ33417613-91D0B4CD-CA02-456F-9F48-6FCB2AE84427Q33419312-59D2C89A-79B4-4BA8-B0A9-9D0EEDFB30C6Q33421822-B0A317FE-51CE-4EF3-A237-B16F3758CBAEQ33423051-10F31BE7-787D-4D53-BAB3-4134FB45848CQ33428744-B39BD33A-5B74-4C36-BCFE-D94E21930E4AQ33430254-B757CDEA-4FA9-429E-8254-B2AC66E9EC62Q33438377-4C31A306-4E9C-4AC8-B742-8368BF916B6DQ35636250-4A2B5D0F-B741-45BD-A48F-AFE0842C89A2Q37790448-712612CE-BEE9-4E9C-AF71-AE9C1D808154Q41892604-BFB38D91-B6CF-43F5-B46D-E565A78AD047Q58690782-A21E6E9F-6975-41C0-A9A2-6EB0B1D8A8B7
P2860
Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Thrombotic thrombocytopenic pu ...... center experience of 48 cases.
@ast
Thrombotic thrombocytopenic pu ...... center experience of 48 cases.
@en
Thrombotic thrombocytopenic pu ...... center experience of 48 cases.
@nl
type
label
Thrombotic thrombocytopenic pu ...... center experience of 48 cases.
@ast
Thrombotic thrombocytopenic pu ...... center experience of 48 cases.
@en
Thrombotic thrombocytopenic pu ...... center experience of 48 cases.
@nl
prefLabel
Thrombotic thrombocytopenic pu ...... center experience of 48 cases.
@ast
Thrombotic thrombocytopenic pu ...... center experience of 48 cases.
@en
Thrombotic thrombocytopenic pu ...... center experience of 48 cases.
@nl
P2093
P356
P1433
P1476
Thrombotic thrombocytopenic pu ...... center experience of 48 cases.
@en
P2093
Dervenoulas J
Economopoulos T
Kostourou A
Papageorgiou E
Tsirigotis P
P356
10.1007/S002770050012
P577
2000-02-01T00:00:00Z